bluebird bio Inc (BLUE):企業の財務・戦略的SWOT分析

◆英語タイトル:bluebird bio Inc (BLUE) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1636
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

bluebird bio Inc (BLUE) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

bluebird bio Inc (bluebird bio) is a clinical stage biotechnology company that focuses on the development of new gene therapies for the treatment of severe genetic diseases and cancer. The company develops its products based on integrated product platforms such as gene therapy, cancer immunotherapy and gene editing. Its product pipeline includes Lenti D for the treatment of cerebral adrenoleukodystrophy (CALD); LentiGlobin for the treatment of transfusion-dependent beta thalassemia and sickle cell disease, besides compounds under development for the treatment of various cancers. The company has collaborations with pharmaceutical companies to discover, develop and commercialize gene therapy products. bluebird bio is headquartered in Cambridge, Massachusetts, the US.

bluebird bio Inc Key Recent Developments

Mar 26,2020 bluebird bio provides assessment of impact of COVID-19, update on business operations and clinical program development
Feb 18,2020 bluebird bio reports fourth quarter and full year 2019 financial results and highlights operational progress
Oct 31,2019 bluebird bio reports third quarter 2019 financial results and highlights operational progress
Oct 23,2019 bluebird bio announces transition of Chief Strategy Officer Jeffrey T. Walsh

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
bluebird bio Inc – Key Facts
bluebird bio Inc – Key Employees
bluebird bio Inc – Key Employee Biographies
bluebird bio Inc – Major Products and Services
bluebird bio Inc – History
bluebird bio Inc – Company Statement
bluebird bio Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
bluebird bio Inc – Business Description
bluebird bio Inc – Corporate Strategy
bluebird bio Inc – SWOT Analysis
SWOT Analysis – Overview
bluebird bio Inc – Strengths
bluebird bio Inc – Weaknesses
bluebird bio Inc – Opportunities
bluebird bio Inc – Threats
bluebird bio Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
bluebird bio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
bluebird bio Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
bluebird bio Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 26, 2020: bluebird bio provides assessment of impact of COVID-19, update on business operations and clinical program development
Feb 18, 2020: bluebird bio reports fourth quarter and full year 2019 financial results and highlights operational progress
Oct 31, 2019: bluebird bio reports third quarter 2019 financial results and highlights operational progress
Oct 23, 2019: bluebird bio announces transition of Chief Strategy Officer Jeffrey T. Walsh
Oct 10, 2019: Novo Nordisk and bluebird bio to develop genetic disease therapies
Oct 09, 2019: bluebird bio and Novo Nordisk enter into research agreement to develop in vivo genome editing candidates for haemophilia and other severe genetic diseases
Sep 27, 2019: bluebird bio appoints William R. Sellers, M.D. to Board of Directors
Aug 01, 2019: bluebird bio reports second quarter 2019 financial results and highlights operational progress
May 09, 2019: bluebird bio’s Analyst Day Highlights Commercial Path to Patients and Research Engine Focused on Next-Generation Gene and Cell Therapies
May 02, 2019: bluebird bio reports first quarter 2019 financial results and highlights operational progress
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
bluebird bio Inc, Key Facts
bluebird bio Inc, Key Employees
bluebird bio Inc, Key Employee Biographies
bluebird bio Inc, Major Products and Services
bluebird bio Inc, History
bluebird bio Inc, Other Locations
bluebird bio Inc, Subsidiaries
bluebird bio Inc, Key Competitors
bluebird bio Inc, Ratios based on current share price
bluebird bio Inc, Annual Ratios
bluebird bio Inc, Annual Ratios (Cont...1)
bluebird bio Inc, Interim Ratios
bluebird bio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
bluebird bio Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
bluebird bio Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
bluebird bio Inc, Performance Chart (2015 - 2019)
bluebird bio Inc, Ratio Charts
bluebird bio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
bluebird bio Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[bluebird bio Inc (BLUE):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • WAVE Life Sciences Ltd (WVE):製薬・医療:M&Aディール及び事業提携情報
    Summary WAVE Life Sciences Ltd (WAVE Life Sciences), formerly WAVE Life Sciences Pte Ltd is a genetic medicine company that develops stereopure nucleic acid therapies. The company's pipeline products comprise multiple oligonucleotide modalities such as exon-skipping and single-stranded RNAi, and ant …
  • University of Florida-製薬・医療分野:企業M&A・提携分析
    Summary University of Florida (UF) is an educational institute that offers undergraduate, graduate and distance learning programs. The institute offers educational programs in areas of agricultural, business administration, journalism and communications, law, dentistry, arts and sciences, medicine, …
  • Superior Energy Services Inc (SPN):企業の財務・戦略的SWOT分析
    Superior Energy Services Inc (SPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Land Bank of Taiwan Co., Ltd:企業の戦略・SWOT・財務情報
    Land Bank of Taiwan Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary Land Bank of Taiwan Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Acura Pharmaceuticals Inc (ACUR):医療機器:M&Aディール及び事業提携情報
    Summary Acura Pharmaceuticals Inc (Acura) is a specialty pharmaceutical company that researches, develops, and commercializes tamper-resistant products to prevent the abuse and misuse of medication. The company’s proprietary technologies, Aversion, Limitx and Impede, are used to prevent product tamp …
  • Eagle Bancorp Inc:企業の戦略・SWOT・財務分析
    Eagle Bancorp Inc - Strategy, SWOT and Corporate Finance Report Summary Eagle Bancorp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Uranium One Inc:企業の戦略的SWOT分析
    Uranium One Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • B&G Foods, Inc.:企業の戦略・SWOT・財務情報
    B&G Foods, Inc. - Strategy, SWOT and Corporate Finance Report Summary B&G Foods, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Sanochemia Pharmazeutika AG (SAC)-製薬・医療分野:企業M&A・提携分析
    Summary Sanochemia Pharmazeutika AG (Sanochemia) is a specialty pharmaceutical company that develops and manufactures of innovative drugs in selected indication areas such as neurodegeneration, pain and cancer, as well as diagnostic products based on contrast media. The company’s product portfolio i …
  • BioCryst Pharmaceuticals Inc (BCRX):製薬・医療:M&Aディール及び事業提携情報
    Summary BioCryst Pharmaceuticals Inc (BioCryst) designs, optimizes and develops small molecule drugs that block key enzymes in the pathogenesis of diseases. The company focuses on the treatment of rare diseases and develops drugs for infectious diseases and hereditary Angioedemaon. Biocryst integrat …
  • Genomic Health Inc (GHDX):医療機器:M&Aディール及び事業提携情報
    Summary Genomic Health Inc (Genomic Health) is a provider of genomic-based diagnostic tests and clinical laboratory services for the diagnosis of cancer. The company’s commercial product portfolio comprises Onco type DX breast cancer test, Onco type DX colon cancer test, Onco type DX prostate cancer …
  • Bracket Global LLC-製薬・医療分野:企業M&A・提携分析
    Summary Bracket Global LLC (Bracket Global) is pharmaceutical company that offers clinical research development services. It strives to bring together science, technology and service to provide superior clinical outcomes for pharmaceutical companies and patients. The company offers services such as …
  • China Yurun Food Group Limited:企業の戦略・SWOT・財務情報
    China Yurun Food Group Limited - Strategy, SWOT and Corporate Finance Report Summary China Yurun Food Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Warner Music Group Corp:企業の戦略的SWOT分析
    Warner Music Group Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Endonovo Therapeutics Inc (ENDV):製薬・医療:M&Aディール及び事業提携情報
    Summary Endonovo Therapeutics Inc (Endonovo Therapeutics) is a commercial stage development company that offers non-invasive medical devices and equipment. The company’s products include Electroceutical Therapy a FDA-Cleared for the palliative treatment of pain and post-surgical edema and CE Marked …
  • ORChem Co., Ltd.:企業のM&A・事業提携・投資動向
    ORChem Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ORChem Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Access Bio Inc (950130):医療機器:M&Aディール及び事業提携情報
    Summary Access Bio Inc (Access Bio) is a medical device company that research, develops, manufactures and markets in-vitro diagnostics tests, biosensor, and molecular diagnostic products. The company provides in vitro diagnostic technology such as immunochemical, biochemical and molecular products. …
  • Celator Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Celator Pharmaceuticals Inc (Celator) is a clinical-stage biopharmaceutical company that develops and distributes therapies for treating cancer disease. The company’s products include cytarabine and daunorubicin liposomal formulation, irinotecan HCI and floxuridine and hydrophobic docetaxel …
  • Bharat Dynamics Limited
    Bharat Dynamics Limited - Strategy, SWOT and Corporate Finance Report Summary Bharat Dynamics Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Torc Oil and Gas Ltd (TOG):石油・ガス:M&Aディール及び事業提携情報
    Summary Torc Oil and Gas Ltd (TORC) is an oil and gas company that offers oil and gas exploration and development services. The company’s services include acquisition, exploration, operations, management, production and development of crude oil and natural gas assets in Western Canadian Sedimentary …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆